The people behind Helix

We’re a rapidly growing company working out of the Bay Area and San Diego.

Scientific Advisory Board

Our advisory board is comprised of the world’s foremost experts in genomics. Each member serves an important role in upholding our high scientific standards and serves as a strategic resource as we build an ongoing destination for DNA discovery.

Marc Stapley

Marc Stapley

Chief Executive Officer

James Lu, MD, PhD

James Lu, MD, PhD

Co-founder & Chief Scientific Officer

Justin Kao

Justin Kao

Co-founder & Chief Business Officer

Debbie Tuck

Debbie Tuck

Chief Financial Officer

Sarah Bobulsky, Senior Director, Strategy & Marketing

Sarah Bobulsky

Senior Director, Strategy & Marketing

Jim Chou

Jim Chou

VP, Engineering

Marc Laurent

Marc Laurent

VP, Partnerships and Operations

Will Lee, PhD

Will Lee, PhD

VP, Bioinformatics

Leslie Liang

Leslie Liang

Head of Legal

David Becker, PhD

David Becker, PhD

VP, Laboratory Operations

Wendy Chung, M.D., Ph.D.

Wendy Chung, M.D., Ph.D.

Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine and Director of Clinical Genetics. Dr. Chung directs research programs in human genetics of obesity, breast cancer, pulmonary hypertension, autism, and more. She is a national leader in the ethical, legal, and social implications of genomics; leads the Precision Medicine Resource in the Irving Institute At Columbia University; and has served on the Institute of Medicine Committee on Genetic Testing.

Nita Farahany, J.D., Ph.D.

Nita Farahany, J.D., Ph.D.

Nita Farahany, J.D., Ph.D. is Professor of Law and Philosophy, Director of Duke Science & Society at Duke University, and a member of the Presidential Commission for the Study of Bioethics. Her research focuses on how developments in behavioral genetics and neuroscience inform societal norms about privacy and individual liberty.

Judy Garber, M.D., MPH

Judy Garber, M.D., MPH

Judy Garber, M.D., MPH is Professor of Medicine at Harvard Medical School and Director, Center for Cancer Genetics and Prevention at Dana Farber Cancer Institute. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer.

Keith Stewart, MB, CHB

Keith Stewart, MB, CHB

Keith Stewart, MB, CHB is the Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine and the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart is responsible for systematically introducing clinical genomics to routine medical practice at Mayo Clinic incorporating prevention, diagnosis and treatment across the spectrum of medical specialties.